Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Dec 17, 2019 at 1:00 PM EST

Why This Multiple Sclerosis Study’s Positive Results May Not Be Enough

Adamas Pharma shares dropped sharply on Tuesday after the firm reported results from its late-stage multiple sclerosis study.

Chris Lange | Dec 17, 2019 at 12:15 PM EST

Why Accelerated Approval Could Be Huge for This Ovarian Cancer Study

ImmunoGen shares jumped on Tuesday after the FDA advised that a new single-arm study in platinum-resistant ovarian cancer could support…

Chris Lange | Dec 17, 2019 at 10:55 AM EST

What’s Next for the Proteostasis Cystic Fibrosis Pipeline

Proteostasis shares were absolutely crushed on Tuesday after the firm announced midstage data from its cystic fibrosis study. What comes…

Douglas A. McIntyre | Dec 17, 2019 at 9:14 AM EST

This Is How to Protect Yourself Against the Flu, According to Doctors

The influenza season officially runs from October to as late as May each year. Activity peaks around the end of…

Chris Lange | Dec 17, 2019 at 9:10 AM EST

Will This Dementia Treatment Be a Big Hit After FDA Decision?

Prevail Therapeutics shares jumped early on Tuesday after the firm announced that the FDA has granted Orphan Drug designation for…

Jon C. Ogg | Dec 16, 2019 at 10:55 AM EST

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Goldman Sachs believes that several health care companies can win, and it has three top picks for 2020 that may…

Chris Lange | Dec 13, 2019 at 10:10 AM EST

Sarepta Catches a Big Break With Duchenne Muscular Dystrophy Drug

Sarepta shares jumped on Friday after the firm announced that the FDA has approved Vyondys 53 (golodirsen) for the treatment…

Jon C. Ogg | Dec 13, 2019 at 9:55 AM EST

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Independent research firm Argus sees better than 25% potential upside for Bristol-Myers Squibb in the coming year.

Chris Lange | Dec 12, 2019 at 12:05 PM EST

Wedbush’s Top Picks After ASH Annual Meeting

The American Society of Hematology (ASH) hosted its 61st annual meeting and one of the biggest biotech events earlier this…

Chris Lange | Dec 12, 2019 at 9:15 AM EST

Why These Breast Cancer Study Results Look So Promising

Puma Biotechnology shares made a handy gain early on Thursday after the company presented updated results from its Phase 2…

Chris Lange | Dec 11, 2019 at 12:20 PM EST

Is This Atrial Fibrillation Drug Done For After FDA Vote?

Correvio Pharma shares were crushed after the firm announced the FDA Cardiovascular and Renal Drugs Advisory Committee decision for its…

Chris Lange | Dec 11, 2019 at 11:10 AM EST

Why This Cystic Fibrosis Study Is Getting a Big Boost

Proteostasis shares jumped on Wednesday after the firm announced positive, initial ex-vivo results of its proprietary cystic fibrosis transmembrane conductance…

Chris Lange | Dec 11, 2019 at 9:45 AM EST

Big Pharma Short Sellers Grow More Selective

The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Dec 11, 2019 at 9:10 AM EST

Major Biotechs See a Rising Tide in Short Interest

The November 29 short interest data has been compared with the previous report, and short interest in most of these…

Paul Ausick | Dec 10, 2019 at 12:00 PM EST

Health Insurance Helps You Live Longer

A new study indicates that the individual mandate portion of the Affordable Care Act (Obamacare) did encourage more people to…

1 … 75 76 77 78 79 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why This Multiple Sclerosis Study’s Positive Results May Not Be Enough

Why Accelerated Approval Could Be Huge for This Ovarian Cancer Study

What’s Next for the Proteostasis Cystic Fibrosis Pipeline

This Is How to Protect Yourself Against the Flu, According to Doctors

Will This Dementia Treatment Be a Big Hit After FDA Decision?

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Sarepta Catches a Big Break With Duchenne Muscular Dystrophy Drug

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Wedbush’s Top Picks After ASH Annual Meeting

Why These Breast Cancer Study Results Look So Promising

Is This Atrial Fibrillation Drug Done For After FDA Vote?

Why This Cystic Fibrosis Study Is Getting a Big Boost

Big Pharma Short Sellers Grow More Selective

Major Biotechs See a Rising Tide in Short Interest

Health Insurance Helps You Live Longer

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

Why This Multiple Sclerosis Study’s Positive Results May Not Be Enough

Why Accelerated Approval Could Be Huge for This Ovarian Cancer Study

What’s Next for the Proteostasis Cystic Fibrosis Pipeline

This Is How to Protect Yourself Against the Flu, According to Doctors

Will This Dementia Treatment Be a Big Hit After FDA Decision?

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Sarepta Catches a Big Break With Duchenne Muscular Dystrophy Drug

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Wedbush’s Top Picks After ASH Annual Meeting

Why These Breast Cancer Study Results Look So Promising

Is This Atrial Fibrillation Drug Done For After FDA Vote?

Why This Cystic Fibrosis Study Is Getting a Big Boost

Big Pharma Short Sellers Grow More Selective

Major Biotechs See a Rising Tide in Short Interest

Health Insurance Helps You Live Longer

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Featured Reads

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500